Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma

Glucose-6-phosphate isomerase (GPI), also known as phosphoglucose isomerase, was initially identified as the second glycolytic enzyme that catalyzes the interconversion of glucose-6-phosphate to fructose-6-phosphate. Later studies demonstrated that GPI was the same as the autocrine motility factor (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Lucarelli, Giuseppe, Rutigliano, Monica, Sanguedolce, Francesca, Galleggiante, Vanessa, Giglio, Andrea, Cagiano, Simona, Bufo, Pantaleo, Maiorano, Eugenio, Ribatti, Domenico, Ranieri, Elena, Gigante, Margherita, Gesualdo, Loreto, Ferro, Matteo, de Cobelli, Ottavio, Buonerba, Carlo, Di Lorenzo, Giuseppe, De Placido, Sabino, Palazzo, Silvano, Bettocchi, Carlo, Ditonno, Pasquale, Battaglia, Michele
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2015
Assuntos:
Observational Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4652838/
https://ncbi.nlm.nih.gov/pubmed/26579829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002117
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados